One aspect of the invention relates to inhibitors that preferentially inhibit immunoproteasome activity over constitutive proteasome activity. In certain embodiments, the invention relates to the treatment of immune related diseases, comprising administering a compound of the invention. In certain embodiments, the invention relates to the treatment of cancer, comprising administering a compound of the invention.

 
Web www.patentalert.com

< Compositions and methods for inhibiting expression of a gene from the JC virus

> Benzimidazole carboxamides as raf kinase inhibitors

> Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds
~ 00595